0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global 3D Printing Pharmaceuticals Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-9W13670
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global 3D Printing Pharmaceuticals Market Research Report 2023
BUY CHAPTERS

Global 3D Printing Pharmaceuticals Market Research Report 2025

Code: QYRE-Auto-9W13670
Report
May 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

3D Printing Pharmaceuticals Market Size

The global market for 3D Printing Pharmaceuticals was valued at US$ 359 million in the year 2024 and is projected to reach a revised size of US$ 613 million by 2031, growing at a CAGR of 8.1% during the forecast period.

3D Printing Pharmaceuticals Market

3D Printing Pharmaceuticals Market

3D printing pharmaceuticals can be applied to the field of solid preparations, which are dominated by small molecule drugs. Compared with traditional solid preparations, 3D printing pharmaceuticals can better control drug release, improve drug efficacy, reduce drug side effects, and reduce dosing frequency.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for 3D Printing Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding 3D Printing Pharmaceuticals.
The 3D Printing Pharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global 3D Printing Pharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the 3D Printing Pharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of 3D Printing Pharmaceuticals Market Report

Report Metric Details
Report Name 3D Printing Pharmaceuticals Market
Accounted market size in year US$ 359 million
Forecasted market size in 2031 US$ 613 million
CAGR 8.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • FDM
  • SLS
  • PB
  • SLA
  • SSE
  • DPE
  • DOD
  • MDD
  • MED
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Triastek,Inc., Aprecia, AstraZeneca, FabRx, Multiply Labs, DiHeSys, Merck, Merck KGaA, TNO, Therics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of 3D Printing Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of 3D Printing Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is 3D Printing Pharmaceuticals Market growing?

Ans: The 3D Printing Pharmaceuticals Market witnessing a CAGR of 8.1% during the forecast period 2025-2031.

What is the 3D Printing Pharmaceuticals Market size in 2031?

Ans: The 3D Printing Pharmaceuticals Market size in 2031 will be US$ 613 million.

Who are the main players in the 3D Printing Pharmaceuticals Market report?

Ans: The main players in the 3D Printing Pharmaceuticals Market are Triastek,Inc., Aprecia, AstraZeneca, FabRx, Multiply Labs, DiHeSys, Merck, Merck KGaA, TNO, Therics

What are the Application segmentation covered in the 3D Printing Pharmaceuticals Market report?

Ans: The Applications covered in the 3D Printing Pharmaceuticals Market report are Personalized Pharmacy, Nutrients

What are the Type segmentation covered in the 3D Printing Pharmaceuticals Market report?

Ans: The Types covered in the 3D Printing Pharmaceuticals Market report are FDM, SLS, PB, SLA, SSE, DPE, DOD, MDD, MED

Recommended Reports

3D Printing Medical

Pharmaceutical Packaging

Advanced Drug Delivery

1 3D Printing Pharmaceuticals Market Overview
1.1 Product Definition
1.2 3D Printing Pharmaceuticals by Type
1.2.1 Global 3D Printing Pharmaceuticals Market Value Comparison by Type (2024 VS 2031)
1.2.2 FDM
1.2.3 SLS
1.2.4 PB
1.2.5 SLA
1.2.6 SSE
1.2.7 DPE
1.2.8 DOD
1.2.9 MDD
1.2.10 MED
1.3 3D Printing Pharmaceuticals by Application
1.3.1 Global 3D Printing Pharmaceuticals Market Value by Application (2024 VS 2031)
1.3.2 Personalized Pharmacy
1.3.3 Nutrients
1.4 Global 3D Printing Pharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global 3D Printing Pharmaceuticals Revenue 2020-2031
1.4.2 Global 3D Printing Pharmaceuticals Sales 2020-2031
1.4.3 Global 3D Printing Pharmaceuticals Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 3D Printing Pharmaceuticals Market Competition by Manufacturers
2.1 Global 3D Printing Pharmaceuticals Sales Market Share by Manufacturers (2020-2025)
2.2 Global 3D Printing Pharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
2.3 Global 3D Printing Pharmaceuticals Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of 3D Printing Pharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of 3D Printing Pharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of 3D Printing Pharmaceuticals, Product Type & Application
2.7 Global Key Manufacturers of 3D Printing Pharmaceuticals, Date of Enter into This Industry
2.8 Global 3D Printing Pharmaceuticals Market Competitive Situation and Trends
2.8.1 Global 3D Printing Pharmaceuticals Market Concentration Rate
2.8.2 The Global 5 and 10 Largest 3D Printing Pharmaceuticals Players Market Share by Revenue
2.8.3 Global 3D Printing Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global 3D Printing Pharmaceuticals Market Scenario by Region
3.1 Global 3D Printing Pharmaceuticals Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global 3D Printing Pharmaceuticals Sales by Region: 2020-2031
3.2.1 Global 3D Printing Pharmaceuticals Sales by Region: 2020-2025
3.2.2 Global 3D Printing Pharmaceuticals Sales by Region: 2026-2031
3.3 Global 3D Printing Pharmaceuticals Revenue by Region: 2020-2031
3.3.1 Global 3D Printing Pharmaceuticals Revenue by Region: 2020-2025
3.3.2 Global 3D Printing Pharmaceuticals Revenue by Region: 2026-2031
3.4 North America 3D Printing Pharmaceuticals Market Facts & Figures by Country
3.4.1 North America 3D Printing Pharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America 3D Printing Pharmaceuticals Sales by Country (2020-2031)
3.4.3 North America 3D Printing Pharmaceuticals Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe 3D Printing Pharmaceuticals Market Facts & Figures by Country
3.5.1 Europe 3D Printing Pharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe 3D Printing Pharmaceuticals Sales by Country (2020-2031)
3.5.3 Europe 3D Printing Pharmaceuticals Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific 3D Printing Pharmaceuticals Market Facts & Figures by Region
3.6.1 Asia Pacific 3D Printing Pharmaceuticals Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific 3D Printing Pharmaceuticals Sales by Region (2020-2031)
3.6.3 Asia Pacific 3D Printing Pharmaceuticals Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America 3D Printing Pharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America 3D Printing Pharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America 3D Printing Pharmaceuticals Sales by Country (2020-2031)
3.7.3 Latin America 3D Printing Pharmaceuticals Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa 3D Printing Pharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa 3D Printing Pharmaceuticals Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2020-2031)
3.8.3 Middle East and Africa 3D Printing Pharmaceuticals Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global 3D Printing Pharmaceuticals Sales by Type (2020-2031)
4.1.1 Global 3D Printing Pharmaceuticals Sales by Type (2020-2025)
4.1.2 Global 3D Printing Pharmaceuticals Sales by Type (2026-2031)
4.1.3 Global 3D Printing Pharmaceuticals Sales Market Share by Type (2020-2031)
4.2 Global 3D Printing Pharmaceuticals Revenue by Type (2020-2031)
4.2.1 Global 3D Printing Pharmaceuticals Revenue by Type (2020-2025)
4.2.2 Global 3D Printing Pharmaceuticals Revenue by Type (2026-2031)
4.2.3 Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2020-2031)
4.3 Global 3D Printing Pharmaceuticals Price by Type (2020-2031)
5 Segment by Application
5.1 Global 3D Printing Pharmaceuticals Sales by Application (2020-2031)
5.1.1 Global 3D Printing Pharmaceuticals Sales by Application (2020-2025)
5.1.2 Global 3D Printing Pharmaceuticals Sales by Application (2026-2031)
5.1.3 Global 3D Printing Pharmaceuticals Sales Market Share by Application (2020-2031)
5.2 Global 3D Printing Pharmaceuticals Revenue by Application (2020-2031)
5.2.1 Global 3D Printing Pharmaceuticals Revenue by Application (2020-2025)
5.2.2 Global 3D Printing Pharmaceuticals Revenue by Application (2026-2031)
5.2.3 Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2020-2031)
5.3 Global 3D Printing Pharmaceuticals Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Triastek,Inc.
6.1.1 Triastek,Inc. Company Information
6.1.2 Triastek,Inc. Description and Business Overview
6.1.3 Triastek,Inc. 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Triastek,Inc. 3D Printing Pharmaceuticals Product Portfolio
6.1.5 Triastek,Inc. Recent Developments/Updates
6.2 Aprecia
6.2.1 Aprecia Company Information
6.2.2 Aprecia Description and Business Overview
6.2.3 Aprecia 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Aprecia 3D Printing Pharmaceuticals Product Portfolio
6.2.5 Aprecia Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca 3D Printing Pharmaceuticals Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 FabRx
6.4.1 FabRx Company Information
6.4.2 FabRx Description and Business Overview
6.4.3 FabRx 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.4.4 FabRx 3D Printing Pharmaceuticals Product Portfolio
6.4.5 FabRx Recent Developments/Updates
6.5 Multiply Labs
6.5.1 Multiply Labs Company Information
6.5.2 Multiply Labs Description and Business Overview
6.5.3 Multiply Labs 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Multiply Labs 3D Printing Pharmaceuticals Product Portfolio
6.5.5 Multiply Labs Recent Developments/Updates
6.6 DiHeSys
6.6.1 DiHeSys Company Information
6.6.2 DiHeSys Description and Business Overview
6.6.3 DiHeSys 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.6.4 DiHeSys 3D Printing Pharmaceuticals Product Portfolio
6.6.5 DiHeSys Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck 3D Printing Pharmaceuticals Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Merck KGaA
6.8.1 Merck KGaA Company Information
6.8.2 Merck KGaA Description and Business Overview
6.8.3 Merck KGaA 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck KGaA 3D Printing Pharmaceuticals Product Portfolio
6.8.5 Merck KGaA Recent Developments/Updates
6.9 TNO
6.9.1 TNO Company Information
6.9.2 TNO Description and Business Overview
6.9.3 TNO 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.9.4 TNO 3D Printing Pharmaceuticals Product Portfolio
6.9.5 TNO Recent Developments/Updates
6.10 Therics
6.10.1 Therics Company Information
6.10.2 Therics Description and Business Overview
6.10.3 Therics 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Therics 3D Printing Pharmaceuticals Product Portfolio
6.10.5 Therics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 3D Printing Pharmaceuticals Industry Chain Analysis
7.2 3D Printing Pharmaceuticals Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 3D Printing Pharmaceuticals Production Mode & Process Analysis
7.4 3D Printing Pharmaceuticals Sales and Marketing
7.4.1 3D Printing Pharmaceuticals Sales Channels
7.4.2 3D Printing Pharmaceuticals Distributors
7.5 3D Printing Pharmaceuticals Customer Analysis
8 3D Printing Pharmaceuticals Market Dynamics
8.1 3D Printing Pharmaceuticals Industry Trends
8.2 3D Printing Pharmaceuticals Market Drivers
8.3 3D Printing Pharmaceuticals Market Challenges
8.4 3D Printing Pharmaceuticals Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global 3D Printing Pharmaceuticals Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global 3D Printing Pharmaceuticals Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global 3D Printing Pharmaceuticals Market Competitive Situation by Manufacturers in 2024
 Table 4. Global 3D Printing Pharmaceuticals Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global 3D Printing Pharmaceuticals Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global 3D Printing Pharmaceuticals Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global 3D Printing Pharmaceuticals Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market 3D Printing Pharmaceuticals Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of 3D Printing Pharmaceuticals, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of 3D Printing Pharmaceuticals, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of 3D Printing Pharmaceuticals, Product Type & Application
 Table 12. Global Key Manufacturers of 3D Printing Pharmaceuticals, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global 3D Printing Pharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in 3D Printing Pharmaceuticals as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global 3D Printing Pharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global 3D Printing Pharmaceuticals Sales by Region (2020-2025) & (K Units)
 Table 18. Global 3D Printing Pharmaceuticals Sales Market Share by Region (2020-2025)
 Table 19. Global 3D Printing Pharmaceuticals Sales by Region (2026-2031) & (K Units)
 Table 20. Global 3D Printing Pharmaceuticals Sales Market Share by Region (2026-2031)
 Table 21. Global 3D Printing Pharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global 3D Printing Pharmaceuticals Revenue Market Share by Region (2020-2025)
 Table 23. Global 3D Printing Pharmaceuticals Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global 3D Printing Pharmaceuticals Revenue Market Share by Region (2026-2031)
 Table 25. North America 3D Printing Pharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America 3D Printing Pharmaceuticals Sales by Country (2020-2025) & (K Units)
 Table 27. North America 3D Printing Pharmaceuticals Sales by Country (2026-2031) & (K Units)
 Table 28. North America 3D Printing Pharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America 3D Printing Pharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe 3D Printing Pharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe 3D Printing Pharmaceuticals Sales by Country (2020-2025) & (K Units)
 Table 32. Europe 3D Printing Pharmaceuticals Sales by Country (2026-2031) & (K Units)
 Table 33. Europe 3D Printing Pharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe 3D Printing Pharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific 3D Printing Pharmaceuticals Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific 3D Printing Pharmaceuticals Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific 3D Printing Pharmaceuticals Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific 3D Printing Pharmaceuticals Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific 3D Printing Pharmaceuticals Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America 3D Printing Pharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America 3D Printing Pharmaceuticals Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America 3D Printing Pharmaceuticals Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America 3D Printing Pharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America 3D Printing Pharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa 3D Printing Pharmaceuticals Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa 3D Printing Pharmaceuticals Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa 3D Printing Pharmaceuticals Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global 3D Printing Pharmaceuticals Sales (K Units) by Type (2020-2025)
 Table 51. Global 3D Printing Pharmaceuticals Sales (K Units) by Type (2026-2031)
 Table 52. Global 3D Printing Pharmaceuticals Sales Market Share by Type (2020-2025)
 Table 53. Global 3D Printing Pharmaceuticals Sales Market Share by Type (2026-2031)
 Table 54. Global 3D Printing Pharmaceuticals Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global 3D Printing Pharmaceuticals Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2020-2025)
 Table 57. Global 3D Printing Pharmaceuticals Revenue Market Share by Type (2026-2031)
 Table 58. Global 3D Printing Pharmaceuticals Price (US$/Unit) by Type (2020-2025)
 Table 59. Global 3D Printing Pharmaceuticals Price (US$/Unit) by Type (2026-2031)
 Table 60. Global 3D Printing Pharmaceuticals Sales (K Units) by Application (2020-2025)
 Table 61. Global 3D Printing Pharmaceuticals Sales (K Units) by Application (2026-2031)
 Table 62. Global 3D Printing Pharmaceuticals Sales Market Share by Application (2020-2025)
 Table 63. Global 3D Printing Pharmaceuticals Sales Market Share by Application (2026-2031)
 Table 64. Global 3D Printing Pharmaceuticals Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global 3D Printing Pharmaceuticals Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2020-2025)
 Table 67. Global 3D Printing Pharmaceuticals Revenue Market Share by Application (2026-2031)
 Table 68. Global 3D Printing Pharmaceuticals Price (US$/Unit) by Application (2020-2025)
 Table 69. Global 3D Printing Pharmaceuticals Price (US$/Unit) by Application (2026-2031)
 Table 70. Triastek,Inc. Company Information
 Table 71. Triastek,Inc. Description and Business Overview
 Table 72. Triastek,Inc. 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Triastek,Inc. 3D Printing Pharmaceuticals Product
 Table 74. Triastek,Inc. Recent Developments/Updates
 Table 75. Aprecia Company Information
 Table 76. Aprecia Description and Business Overview
 Table 77. Aprecia 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Aprecia 3D Printing Pharmaceuticals Product
 Table 79. Aprecia Recent Developments/Updates
 Table 80. AstraZeneca Company Information
 Table 81. AstraZeneca Description and Business Overview
 Table 82. AstraZeneca 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. AstraZeneca 3D Printing Pharmaceuticals Product
 Table 84. AstraZeneca Recent Developments/Updates
 Table 85. FabRx Company Information
 Table 86. FabRx Description and Business Overview
 Table 87. FabRx 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. FabRx 3D Printing Pharmaceuticals Product
 Table 89. FabRx Recent Developments/Updates
 Table 90. Multiply Labs Company Information
 Table 91. Multiply Labs Description and Business Overview
 Table 92. Multiply Labs 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Multiply Labs 3D Printing Pharmaceuticals Product
 Table 94. Multiply Labs Recent Developments/Updates
 Table 95. DiHeSys Company Information
 Table 96. DiHeSys Description and Business Overview
 Table 97. DiHeSys 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. DiHeSys 3D Printing Pharmaceuticals Product
 Table 99. DiHeSys Recent Developments/Updates
 Table 100. Merck Company Information
 Table 101. Merck Description and Business Overview
 Table 102. Merck 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Merck 3D Printing Pharmaceuticals Product
 Table 104. Merck Recent Developments/Updates
 Table 105. Merck KGaA Company Information
 Table 106. Merck KGaA Description and Business Overview
 Table 107. Merck KGaA 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Merck KGaA 3D Printing Pharmaceuticals Product
 Table 109. Merck KGaA Recent Developments/Updates
 Table 110. TNO Company Information
 Table 111. TNO Description and Business Overview
 Table 112. TNO 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. TNO 3D Printing Pharmaceuticals Product
 Table 114. TNO Recent Developments/Updates
 Table 115. Therics Company Information
 Table 116. Therics Description and Business Overview
 Table 117. Therics 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Therics 3D Printing Pharmaceuticals Product
 Table 119. Therics Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. 3D Printing Pharmaceuticals Distributors List
 Table 123. 3D Printing Pharmaceuticals Customers List
 Table 124. 3D Printing Pharmaceuticals Market Trends
 Table 125. 3D Printing Pharmaceuticals Market Drivers
 Table 126. 3D Printing Pharmaceuticals Market Challenges
 Table 127. 3D Printing Pharmaceuticals Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of 3D Printing Pharmaceuticals
 Figure 2. Global 3D Printing Pharmaceuticals Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global 3D Printing Pharmaceuticals Market Share by Type: 2024 & 2031
 Figure 4. FDM Product Picture
 Figure 5. SLS Product Picture
 Figure 6. PB Product Picture
 Figure 7. SLA Product Picture
 Figure 8. SSE Product Picture
 Figure 9. DPE Product Picture
 Figure 10. DOD Product Picture
 Figure 11. MDD Product Picture
 Figure 12. MED Product Picture
 Figure 13. Global 3D Printing Pharmaceuticals Market Value by Application (2020-2031) & (US$ Million)
 Figure 14. Global 3D Printing Pharmaceuticals Market Share by Application: 2024 & 2031
 Figure 15. Personalized Pharmacy
 Figure 16. Nutrients
 Figure 17. Global 3D Printing Pharmaceuticals Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global 3D Printing Pharmaceuticals Market Size (2020-2031) & (US$ Million)
 Figure 19. Global 3D Printing Pharmaceuticals Sales (2020-2031) & (K Units)
 Figure 20. Global 3D Printing Pharmaceuticals Average Price (US$/Unit) & (2020-2031)
 Figure 21. 3D Printing Pharmaceuticals Report Years Considered
 Figure 22. 3D Printing Pharmaceuticals Sales Share by Manufacturers in 2024
 Figure 23. Global 3D Printing Pharmaceuticals Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest 3D Printing Pharmaceuticals Players: Market Share by Revenue in 3D Printing Pharmaceuticals in 2024
 Figure 25. 3D Printing Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global 3D Printing Pharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America 3D Printing Pharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 28. North America 3D Printing Pharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 29. United States 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe 3D Printing Pharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 32. Europe 3D Printing Pharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 33. Germany 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific 3D Printing Pharmaceuticals Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific 3D Printing Pharmaceuticals Revenue Market Share by Region (2020-2031)
 Figure 40. China 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. China Taiwan 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Southeast Asia 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America 3D Printing Pharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 48. Latin America 3D Printing Pharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa 3D Printing Pharmaceuticals Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa 3D Printing Pharmaceuticals Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE 3D Printing Pharmaceuticals Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of 3D Printing Pharmaceuticals by Type (2020-2031)
 Figure 58. Global Revenue Market Share of 3D Printing Pharmaceuticals by Type (2020-2031)
 Figure 59. Global 3D Printing Pharmaceuticals Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of 3D Printing Pharmaceuticals by Application (2020-2031)
 Figure 61. Global Revenue Market Share of 3D Printing Pharmaceuticals by Application (2020-2031)
 Figure 62. Global 3D Printing Pharmaceuticals Price (US$/Unit) by Application (2020-2031)
 Figure 63. 3D Printing Pharmaceuticals Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS